Evaluating bradykinesia: How many finger taps are needed?
Objective: To assess the utility of finger tapping (FT) test to evaluate bradykinesia in Parkinson's disease (PD) at short and long FT sequences. Background: Repetitive…Changes in motor symptoms of Parkinson’s disease: 2-year follow-up of 735 cases
Objective: This study is aimed at assessing and interpreting the changes in motor rating scales for Parkinson's disease (PD) over a 2-year longitudinal study. Background:…Beliefs and knowledge on Parkinson’s disease (PD) among people with PD, the public and traditional healers in Western Cape, South Africa
Objective: To determine belief systems and knowledge about PD among patients with PD, among the public and among traditional healers. Background: Parkinson's disease (PD) is…A community organizing approach to identify and address the barriers to healthcare for XDP patients in Panay Island, Philippines
Objective: To identify (1) the barriers to healthcare for a rural, indigent population of XDP patients whose care is centered at a health center by…The effect of walking speed on postural stability in Parkinson’s disease fallers
Objective: This cross-sectional study aimed to evaluate the effect of imposed faster and slower walking speeds on gait rhythmicity in people with Parkinson's disease (PD)…Subcutaneous apomorphine reduces OFF time and dyskinesias and improves quality of life in Parkinson’s disease (PD) – 5-year follow-up of patients in Greece
Objective: To evaluate the long-term efficacy of subcutaneous apomorphine (APO) injection and APO infusion in controlling motor fluctuations and dyskinesias and the impact on quality…Serum level of vitamin D3 in patients with neurodegenerative diseases compared to healthy adults and its correlation with the years spent from the initial diagnosis
Objective: Vitamin D is an important factor responsible for many physiologic functions. Vitamin D deficiency is associated with increased risk of neurodegenerative disease. Background: The…Association of Parkinson’s disease with essential tremor
Objective: In this study we present the clinical characteristics of 10 patients (6 males, 4 females) with both essential tremor (ET) and Parkinson's disease (PD).…ADS-5102 (amantadine HCl) extended-release capsules reduced levodopa-induced dyskinesia in the phase 3 EASE LID study
Objective: To investigate the efficacy and safety of ADS-5102 (amantadine HCl) extended release capsules 340 mg daily at bedtime for the treatment of levodopa-induced dyskinesia…The impact of STN DBS on kinetic tremor in Parkinson’s disease patients
Objective: The aim of the study is to evaluate the impact of STN DBS on kinetic tremor in PD patients in comparison to pharmacologically treated…
- « Previous Page
- 1
- …
- 378
- 379
- 380
- 381
- 382
- …
- 405
- Next Page »